The FDA has even permitted a drug produced with cannabidiol for that reason (Epidiolex). However the company only suggests it for 2 scarce kinds of childhood epilepsy identified as Lennox-Gastaut syndrome and Dravet syndrome. Study will proceed to explore potential therapeutic effects of cannabis